Diagnostic Biomarkers Market Size

  • Report ID: 3086
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Diagnostic Biomarkers Market size was over USD 62.43 billion in 2024 and is projected to reach USD 263.08 billion by 2037, witnessing around 11.7% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of diagnostic biomarkers is assessed at USD 68.64 billion.

The growth of the market can be attributed to the rising prevalence of diseases, such as, cancer, and diabetes, combined with the increasing demand for early diagnosis of such disease. Early diagnosis can significantly reduce the risk of complications and improve the chances of recovery. According to a report by the World Health Organization (WHO), cancer caused over 10 million deaths in 2020. The major type of cancers included lung, colon-rectal, liver and breast cancer, which are all treatable, if diagnosed on time. Lung cancer was the cause of 1.80 million deaths, whereas 935 000 deaths were caused by colon and rectum cancer; liver cancer was responsible for 830 000 deaths of the total deaths and breast cancer caused 685000 deaths. Moreover, rising demand for advanced treatment options and growing R&D investment for medical research, are estimated to further boost the market growth.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of diagnostic biomarkers is assessed at USD 68.64 billion.

Diagnostic Biomarkers Market size was over USD 62.43 billion in 2024 and is projected to reach USD 263.08 billion by 2037, witnessing around 11.7% CAGR during the forecast period i.e., between 2025-2037.

North America industry is likely to account for largest revenue share by 2037, impelled by efficient healthcare sector, supported by high government investment.

The major players in the market are PerkinElmer Inc., Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH and others.

Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos